TrianglePUBLICATIONS · 21768474
Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2011 Aug 20
- First author
- Inaba H
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Inaba H
- type
- Author
- name
- Rubnitz JE
- type
- Author
- name
- Coustan-Smith E
- type
- Author
- name
- Li L
- type
- Author
- name
- Furmanski BD
- type
- Author
- name
- Mascara GP
- type
- Author
- name
- Heym KM
- type
- Author
- name
- Christensen R
- type
- Author
- name
- Onciu M
- type
- Author
- name
- Shurtleff SA
- type
- Author
- name
- Pounds SB
- type
- Author
- name
- Pui CH
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Inaba H
- type
- Author
- name
- Rubnitz JE
- type
- Author
- name
- Coustan-Smith E
- type
- Author
- name
- Li L
- type
- Author
- name
- Furmanski BD
- type
- Author
- name
- Mascara GP
- type
- Author
- name
- Heym KM
- type
- Author
- name
- Christensen R
- type
- Author
- name
- Onciu M
- type
- Author
- name
- Shurtleff SA
- type
- Author
- name
- Pounds SB
- type
- Author
- name
- Pui CH
- type
- Author
- bibliography ids
- nci-bib-c1bacb85833fc648030b9311
- book metadata
- content sha256
- c1656bd1609384e3a2c8c250d08db45d36faa1270d4a3ec354373301d3d35ba4
- document type
- citation
- dois
- 10.1200/JCO.2011.34.7427
- electronic publication date
- display
- 2011 Jul 18
- precision
- day
- year
- 2011
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21768474
- immutable id
- pubmed:21768474@c1656bd1609384e3a2c8c250d08db45d36faa1270d4a3ec354373301d3d35ba4
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 24
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3293-300
- volume
- 29
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21768474
- provenance
- batch id
- 2529ef2eca926738ab13
- provider
- NCBI PubMed ESummary
- record sha256
- f0e0c8cce3abb9eba360ea5743dcd8a8b5d1e2287e8df7d96a308c33b00f0898
- response sha256
- 9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
- retrieved at
- 2026-09-09T23:46:42.856296+00:00
- publication date
- display
- 2011 Aug 20
- precision
- day
- year
- 2011
- publication types
- Clinical Trial, Phase I
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia.
Preserved source evidence · Not medical advice